APA (7th ed.) Citation

Zhongling Zhu, Teng Jiang, Huirong Suo, Shan Xu, Cai Zhang, Guoguang Ying, . . . Zhao Yan. (2021). Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/mTOR and ROS-Mediated Signaling Pathways. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Zhongling Zhu, Teng Jiang, Huirong Suo, Shan Xu, Cai Zhang, Guoguang Ying, Zhao Yan, and Zhao Yan. Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/mTOR and ROS-Mediated Signaling Pathways. Frontiers Media S.A., 2021.

MLA (9th ed.) Citation

Zhongling Zhu, et al. Metformin Potentiates the Effects of Anlotinib in NSCLC via AMPK/mTOR and ROS-Mediated Signaling Pathways. Frontiers Media S.A., 2021.